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Abstract
Acetylation of α-tubulin was studied in cultures of human hepatocytes under the influence of
selective  inhibitors  of  histone  deacetylases  HDAC6  and  SIRT-2  -  tubastatin  A  and  2-(-
-phenethoxyphenylamino)benzamide,  respectively.  It  was found that  in  hepatocyte cell  line
HepG2 acetylated α-tubulin is accumulated preferentially on inhibition of HDAC6 but not of SIRT-
2. Under the same conditions, no acetylation of α-tubulin was observed in hepatocyte cell line
Huh7. However, the inhibition of HDAC6 with tubastatin A led to hyperacetylation of α-tubulin
and simultaneously to decrease in viral RNA concentration in hepatocyte cell line Huh7-luc/neo,
which supports propagation of the full genome replicon of hepatitis C virus. The correlation
between these two processes points to HDAC6 as a promising cellular target for therapy of
hepatitis C. © 2014 Pleiades Publishing, Ltd.
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